Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bionic eye implant aims to bring back central sight in rare vision loss

NCT ID NCT07266584

Recruiting now Disease control Sponsor: Science Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a device called PRIMA, which is implanted under the retina to help people with inherited retinal diseases like Stargardt disease and retinitis pigmentosa see better. The trial will enroll 5 adults with severe central vision loss and measure improvements in visual acuity and safety. The goal is to gather data to support further development of the implant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PRIMA retinal implant (a device placed under the retina to stimulate remaining cells)
What this could lead to
If it works, this could provide a way to improve central vision in people with severe vision loss from inherited retinal diseases.
What could go wrong
This is a very small early study with only 5 participants, so results may not apply widely. The implant is a device and carries surgical risks, and vision improvement may be modest or not occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INHERITED RETINAL DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inherited retinal dystrophy retinitis pigmentosa Stargardt disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INHERITED RETINAL DEGENERATION RETINITIS PIGMENTOSA (RP) STARGARDT DISEASE

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Sydney Eye Hospital

    RECRUITING

    Sydney, New South Wales, 2006, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.